Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model

التفاصيل البيبلوغرافية
العنوان:	Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model
المؤلفون:	Hendrix, Nathaniel, Oestreicher, Nina, Lalla, Deepa, Dolan, Chantal M., Fisher, Kathryn A., Veenstra, David L., Moy, Beverly
المصدر:	In Clinical Breast Cancer December 2022 22(8):781-791
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	15268209
DOI:	10.1016/j.clbc.2022.08.012